Skip to main content
Menu
US

HTRF Human & Mouse Phospho-p62 (SQSTM1) (Ser403) Detection Kit, 500 Assay Points

P62/sqstm1 P-s403 Kit - 50,000 Tests

Click to copy promo code to clipboard.
img-icon-10-off-white-yellow.svg

SAVE 10% on your first Revvity.com order. Use promo code below.

HELLO10

Terms and conditions apply.

Feature Specification
Application Cell Signaling
Sample Volume 16 µL

P62/sqstm1 P-s403 Kit - 50,000 Tests

Click to copy promo code to clipboard.
img-icon-10-off-white-yellow.svg

SAVE 10% on your first Revvity.com order. Use promo code below.

HELLO10

Terms and conditions apply.

Product Variants
Unit Size: 500 assay points
Part #:
64P62S4PEG
List Price
USD 2,271.53
Your online price:
Unit Size: 10,000 assay points
Part #:
64P62S4PEH
List Price
USD 13,214.42
Your online price:
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption, and disposal requirements under European REACH regulations (EC 1907/2006).

Overview

This HTRF cell-based assay conveniently and accurately quantifies phosphorylated p62/SQSTM1 at Ser403. p62/SQSTM1 is a ubiquitin-binding protein Involved in the regulation of autophagy. This is a cellular mechanism which enables the clearance of abnormal proteins or organelles, and it plays a role in cancer, neurodegenerative diseases, as well as cardiovascular and infectious diseases.

p62/SQSTM1 functions as a bridge between polyubiquitinated cargo protein and autophagosomes by interacting directly with both the cargo protein and a protein called LC3, which is involved in autophagosome formation. Recently, p62/SQSTM1 activation has been associated with ULK1 and mTor- induced phosphorylation on different residues, like Ser 403.

The activated autophagy pathway promotes the degradation of p62-associated ubiquitinated protein cargoes.

Specifications

Application
Cell Signaling
Brand
HTRF
Detection Modality
HTRF
Lysis Buffer Compatibility
Lysis Buffer 1
Lysis Buffer 4
Lysis Buffer 5
Molecular Modification
Phosphorylation
Product Group
Kit
Sample Volume
16 µL
Shipping Conditions
Shipped in Dry Ice
Target Class
Phosphoproteins
Target Species
Human
Mouse
Technology
TR-FRET
Therapeutic Area
Cardiovascular
Infectious Diseases
Neuroscience
Oncology & Inflammation
Unit Size
500 assay points

Video gallery

How it works

Phospho-p62/SQSTM1 (Ser403) assay principle

Revvity's Phospho-p62/SQSTM1 (Ser403) assay measures p62 when phosphorylated at Ser403. Unlike Western Blot, the assay is entirely plate-based and does not require gels, electrophoresis, or transfer. The Phospho-p62 (Ser403) assay uses 2 labeled antibodies, one with a donor fluorophore and the other with an acceptor. The first antibody is selected for its specific binding to the phosphorylated motif on the protein, the second for its ability to recognize the protein independent of its phosphorylation state. Protein phosphorylation enables an immune complex formation involving the two labeled antibodies, which brings the donor fluorophore into close proximity to the acceptor and thereby generates a FRET signal. Its intensity is directly proportional to the concentration of phosphorylated protein present in the sample, and provides a means of assessing the protein's phosphorylation state under a no-wash assay format.

phospho-how-it-works-phospho-p62-s403-assay-principle

 

Phospho-p62/SQSTM1 (Ser403) two-plate assay protocol

The two-plate protocol involves culturing cells in a 96-well plate before lysis, then transferring lysates into a low volume detection plate (either HTRF 384-lv or 96-lv plate) before the addition of HTRF Phospho-p62/SQSTM1 (Ser403) detection reagents. This protocol enables the cells' viability and confluence to be monitored.

phospho-p62-s403-2-plate-assay-protocol

 

Phospho-p62/SQSTM1 (Ser403) one-plate assay protocol

Detection of Phosphorylated p62/SQSTM1 (Ser 403) with HTRF reagents can be performed in a single plate used for culturing, stimulation, and lysis. No washing steps are required. This HTS designed protocol enables miniaturization while maintaining robust HTRF quality.

phospho-p62-s403-1-plate-assay-protocol

 

Assay validation

Expression and phosphorylation of p62/SQSTM1 on Ser403 in untreated cells

Human HeLa and SH-SY5Y cells, and mouse Neuro2a cells were plated at 100,000 and 120,000 and 50,000 cells/well in a 96 well plate, respectively .

After an incubation of 24h at 37°C, 5% CO2, the cell culture medium was discarded, and 50µL of supplemented lysis buffer #4 (1X) added.

After 30min lysis at RT under gentle shaking, lysates were transferred into a low volume detection microplate as follows:

16µL of lysate for the detection of phospho-p62/SQSTM1 (S403)

4 µl of lysate, then 12 µL of supplemented lysis buffer #4 (1X) for the detection of total p62/SQSTM1.

Finally, 4µL of the HTRF phospho (Ser403) or total p62/SQSTM1 detection reagents were added. The HTRF signal was recorded after an overnight incubation.

Whereas the expression of p62/SQSTM1 is evidenced in untreated cell lines assessed here, its phosphorylation level is elevated in Neuro2A cells only.

Beside demonstrating the compatibility of the assays with human and mouse samples, these results suggest differences in p62/SQSTM1 behavior depending on the cellular background.

assay-validation-p62-phospho-s403-1

 

Bafilomycin A1 dose-response

Human HeLa and SH-SY5Y cells were plated at respectively 100,000 and 120,000 cells/well in a 96 well plate, and incubated 24h at 37°C, 5% CO2.

After overnight incubation with increasing concentrations of Bafilomycin A1, which is a well established autophagic flux blocker, the cell culture medium was removed, and cells were lysed with 50 µL of supplemented lysis buffer #4 (1X). After 30min lysis at RT under gentle shaking, lysates were transferred into a low volume detection microplate as follows:

16µL of lysate for the detection of phospho-p62/SQSTM1 (S403).

4 µl of lysate then 12 µL of supplemented lysis buffer #4 (1X) for the detection of total p62/SQSTM1.

Finally, 4µL of the HTRF phospho (Ser403) or total p62/SQSTM1 detection reagents were added. The HTRF signal was recorded after an overnight incubation.

As expected, increasing concentrations of Bafilomycin A1 are associated with a dose dependent increase of both expression and S403 phosphorylation of p62/SQSTM1.

Note that Bafilomycin EC50 is approximately 20nM, and comparable between Hela and SH-SY5Y cells.

assay-validation-p62-phospho-s403-2

 

assay-validation-p62-phospho-s403-3

 

Starvation 6h on HeLa cells

Human HeLa cells were plated at 100,000 cells/well in a 96 well plate. After 24h incubation, cell culture medium was removed and replaced by EBSS (an amino acid and vitamin deprived medium) or fresh culture medium for 6h.

Next, cells were lysed with 50 µL of supplemented lysis buffer #4 (1X). After 30min lysis at RT under gentle shaking, lysates were transferred into a low volume detection microplate as follows:

16µL of lysate for the detection of phospho-p62/SQSTM1 (S403).

4 µl of lysate, then 12 µL of supplemented lysis buffer #4 (1X) for the detection of total p62/SQSTM1.

Finally, 4µL of the HTRF phospho (Ser403) or total p62/SQSTM1 detection reagents were added. The HTRF signal was recorded after an overnight incubation.

As expected, amino acid deprivation conditions are associated with a decrease in total p62/SQSTM1, which results from an autophagy-induced degradation mechanism.

assay-validation-p62-phospho-s403-4

 

PP242 dose-response

Human HeLa cells and SH-SY5Y cells were plated at respectively 100,000 and 120,000 cells/well in a 96 well plate.

After cell treatment (Hela: 6H; SH-SY5Y: ON) with increasing concentrations of an autophagic inducer, PP242, the culture medium was removed.

Next, cells were lysed with 50 µL of supplemented lysis buffer #4 (1X). After 30 min lysis at RT under gentle shaking, lysates were transferred into a low volume detection microplate as follows:

16 µL of lysate for the detection of phospho-p62/SQSTM1 (S403).

4 µL of lysate, then 12 µL of supplemented lysis buffer #4 (1X) for the detection of total p62/SQSTM1.

Finally, 4 µL of the HTRF phospho (Ser403) or total p62/SQSTM1 detection reagents were added. The HTRF signal was recorded after an overnight incubation.

These results show that the p62/SQSTM1 level is reduced upon PP242 treatment, resulting from a degradation induced by the autophagic pathway.

assay-validation-p62-phospho-s403-5

 

assay-validation-p62-phospho-s403-6

 

HTRF phospho-p62/SQSTM1 (Ser403) cellular assay compared to Western Blot

Human HeLa cells were grown for 2 days, until 80% confluency was reached. Then the cells were stimulated with MG-132 (4 µM) overnight, before lysis with supplemented lysis buffer, and soluble supernatants were collected via centrifugation.

Serial dilutions of the cell lysate in supplemented lysis buffer #4 (1X) were performed, and 16µL of lysates were transferred into a HTRF low volume detection microplate prior to the addition of 4µL of HTRF phospho-p62/SQSTM1 (S403) detection reagents.

A side by side comparison of Western Blot and HTRF demonstrates that the HTRF assay is 4-fold more sensitive than the Western Blot, at least under these experimental conditions.

 

Simplified pathway

Simplified pathway for p62/SQSTM1 assays

Autophagy is a physiological cellular process enabling the clearing out of misfolded or aggregated proteins, or damaged organelles like mitochondria, also called mitophagy. Activated upon oxidative stress, nutrient deprivation, infections (xenophagy), or during the development of cancers or neurodegenerative diseases, the autophagy pathway relies on key players such as p62/SQSTM1, ATG proteins, or LC3.

p62 / SQSTM1 is an adaptor protein which is initially phosphorylated by ULK1 on Serine 407, then on Serine 403 by casein kinase 2 or TBK1. The phosphorylation on Ser403 increases its affinity for ubiquitin chains, thus enabling p62/SQSTM1 to bind to ubiquitinated cargo proteins. Ubiquitinated proteins or ubiquitin coated mitochondria associated with p62SQSTM1 proteins are taken away in phagosomes, whose content is cleared out after lysosomal fusion.

In addition, another p62/SQSTM1 phosphorylation residue has been reported on Ser349 upon oxidative stress or amino acid deprivation. This phosphorylation event abrogates the interaction between Keap1 and the transcription factor Nrf2 which translocates into the nucleus, where it activates the transcription of antioxidant genes including p62/SQSTM1. In parallel, cytoplasmic Keap1 is captured by p62/SQSTM1 and is degraded by autophagic clearance.

Apart from the role of p62/SQSTM1 in addressing unwanted cargoes to autophagic clearance, other components are essential in the autophagy process. Among them are ULK1 and VSP34 complexes, as well as the conjugation machinery composed of the ATG protein family and LC3-II which are sequentially involved in the formation of phagophores. Phagophores evolve to autophagosomes which fuse with lysosomes, giving rise to autolysosomes where enzymes like protease or phosphatases are active.

phospho-pathway-p62-sqstm1-phospho-s403-64p62s4peg

 

Resources

Are you looking for resources, click on the resource type to explore further.

1-5 of 5 Resources
Brochure Icon
Brochure
HTRF assays and reagents catalog

Discover the versatility and precision of Homogeneous Time-Resolved Fluorescence (HTRF) technology. Our HTRF portfolio offers a...

Guide Icon
Guide
HTRF solutions, guide to major applications

This guide provides you an overview of HTRF applications in several therapeutic areas.

Guide Icon
Guide
Protein degradation awareness in a single guide

An in-depth review of molecular and cellular pathways

The maintenance of proteostasis, the biological mechanisms that control the...

Whitepaper Icon
Whitepaper
Shifting the treatment paradigm: the promise of gene therapy for neurodegenerative diseases

Neurodegenerative diseases, such as Alzheimer’s, Parkinson’s, and Huntington’s, are complex disorders that affect millions...

Whitepaper Icon
Whitepaper
Targeted protein degradation: A novel therapeutic strategy for neurodegenerative diseases

Targeted protein degradation (TPD) offers a promising approach for treating neurodegenerative diseases by selectively degrading...

Scroll Icon